2025
SJR Q1
JCR Q3 · 2,3
19 matched articles
SCIE
Journal detail
Journal of Acquired Immune Deficiency Syndromes (1999)
- Publisher
- Wolters Kluwer Health
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1525413519447884
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,066
- Quartile Q1
- H-Index 180
- Cites/doc 2,04
- Docs (3y) 702
- Cites (3y) 1.612
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,3
- 5Y JIF 2,8
- JCI 0,62
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Infectious Diseases Q1
- Pharmacology (medical) Q1
Areas
- Medicine
WoS categories
- Immunology | Infectious Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q3 | 1,066 | 2,3 | 2,8 | 0,62 | Q3 | 180 |
| 2024 | Q1 | Q3 | 1,04 | 2,2 | 2,8 | 0,62 | Q3 | 176 |
| 2023 | Q1 | Q2 | 1,225 | 2,9 | 3 | 0,6 | Q2 | 176 |
| 2022 | Q1 | Q3 | 1,278 | 3,6 | 3,5 | 0,68 | Q2 | 176 |
| 2021 | Q1 | Q3 | 1,469 | 3,8 | 4,1 | 0,73 | Q2 | 176 |
| 2020 | Q1 | Q2 | 2,162 | 3,7 | 4,1 | 0,94 | Q2 | 176 |
| 2019 | Q1 | Q2 | 2,165 | 3,5 | 3,7 | 1,04 | Q2 | 176 |
| 2018 | — | Q1 | — | 3,9 | 3,8 | 1,12 | Q1 | — |
| 2017 | Q1 | Q1 | 2,368 | 4,1 | 4 | 1,11 | Q1 | 176 |
| 2016 | Q1 | Q1 | 2,361 | 3,9 | 3,9 | — | — | 176 |
| 2015 | Q1 | Q1 | 2,528 | 3,8 | 4 | — | — | 176 |
| 2014 | Q1 | Q1 | 2,697 | 4,6 | 4,5 | — | — | 176 |
| 2013 | Q1 | Q1 | 2,929 | 4,4 | 4,5 | — | — | 176 |
| 2012 | Q1 | Q1 | 2,883 | 4,7 | 4,6 | — | — | 176 |
| 2011 | Q1 | Q1 | 2,64 | 4,4 | 4,6 | — | — | 176 |
| 2010 | Q1 | Q1 | 2,934 | 4,3 | 4,5 | — | — | 176 |
| 2009 | — | Q1 | — | 4,2 | 4,3 | — | — | — |
| 2008 | — | Q1 | — | 4,6 | 4,4 | — | — | — |
| 2007 | — | Q1 | — | 4,4 | 4,5 | — | — | — |
| 2006 | — | Q1 | — | 3,9 | — | — | — | — |
| 2005 | — | Q1 | — | 3,9 | — | — | — | — |
| 2004 | — | Q1 | — | 4,1 | — | — | — | — |
| 2003 | — | Q1 | — | 3,7 | — | — | — | — |
| 2002 | — | Q1 | — | 3,9 | — | — | — | — |
| 2001 | — | Q1 | — | 3,6 | — | — | — | — |
| 2000 | — | Q1 | — | 3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q3 | Q3 | 135/183 |
| 2025 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 87/141 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q3 | 135/183 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 82/137 |
| 2023 | IMMUNOLOGY | SCIE | Q3 | Q3 | 108/181 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 58/132 |
| 2022 | IMMUNOLOGY | SCIE | Q3 | Q2 | 99/161 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 52/96 |
| 2021 | IMMUNOLOGY | SCIE | Q3 | Q2 | 107/162 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 57/95 |
| 2020 | IMMUNOLOGY | SCIE | Q3 | Q2 | 95/162 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 40/93 |
| 2019 | IMMUNOLOGY | SCIE | Q2 | Q2 | 79/159 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 34/92 |
| 2018 | IMMUNOLOGY | SCIE | Q2 | Q1 | 61/158 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 22/89 |
| 2017 | IMMUNOLOGY | SCIE | Q2 | Q1 | 49/155 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 20/88 |
| 2016 | IMMUNOLOGY | SCIE | Q2 | — | 46/151 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q1 | — | 20/84 |
| 2015 | IMMUNOLOGY | SCIE | Q2 | — | 51/151 |
| 2015 | INFECTIOUS DISEASES | SCIE | Q1 | — | 18/83 |
| 2014 | IMMUNOLOGY | SCIE | Q1 | — | 29/148 |
| 2014 | INFECTIOUS DISEASES | SCIE | Q1 | — | 12/78 |
| 2013 | IMMUNOLOGY | SCIE | Q1 | — | 30/144 |
| 2013 | INFECTIOUS DISEASES | SCIE | Q1 | — | 10/72 |
| 2012 | IMMUNOLOGY | SCIE | Q1 | — | 30/137 |
| 2012 | INFECTIOUS DISEASES | SCIE | Q1 | — | 10/70 |
| 2011 | IMMUNOLOGY | SCIE | Q1 | — | 30/139 |
| 2011 | INFECTIOUS DISEASES | SCIE | Q1 | — | 11/70 |
| 2010 | IMMUNOLOGY | SCIE | Q1 | — | 27/134 |
| 2010 | INFECTIOUS DISEASES | SCIE | Q1 | — | 10/58 |
| 2009 | IMMUNOLOGY | SCIE | Q1 | — | 26/128 |
| 2009 | INFECTIOUS DISEASES | SCIE | Q1 | — | 9/57 |
| 2008 | IMMUNOLOGY | SCIE | Q1 | — | 24/121 |
| 2008 | INFECTIOUS DISEASES | SCIE | Q1 | — | 6/51 |
| 2007 | IMMUNOLOGY | SCIE | Q1 | — | 22/119 |
| 2007 | INFECTIOUS DISEASES | SCIE | Q1 | — | 8/50 |
| 2006 | IMMUNOLOGY | SCIE | Q1 | — | 29/117 |
| 2006 | INFECTIOUS DISEASES | SCIE | Q1 | — | 10/47 |
| 2005 | IMMUNOLOGY | SCIE | Q1 | — | 25/115 |
| 2005 | INFECTIOUS DISEASES | SCIE | Q1 | — | 10/43 |
| 2004 | IMMUNOLOGY | SCIE | Q1 | — | 18/111 |
| 2004 | INFECTIOUS DISEASES | SCIE | Q1 | — | 7/41 |
| 2003 | IMMUNOLOGY | SCIE | Q1 | — | 24/114 |
| 2003 | INFECTIOUS DISEASES | SCIE | Q1 | — | 7/41 |
| 2002 | IMMUNOLOGY | SCIE | Q1 | — | 22/119 |
| 2002 | INFECTIOUS DISEASES | SCIE | Q1 | — | 7/38 |
| 2001 | IMMUNOLOGY | SCIE | Q1 | — | 22/114 |
| 2001 | INFECTIOUS DISEASES | SCIE | Q1 | — | 6/37 |
| 2000 | IMMUNOLOGY | SCIE | Q1 | — | 24/116 |
| 2000 | INFECTIOUS DISEASES | SCIE | Q1 | — | 7/36 |